Aspireon Wealth Advisors Rani Therapeutics Holdings, Inc. Transaction History
Aspireon Wealth Advisors
- $183 Million
- Q1 2023
A detailed history of Aspireon Wealth Advisors transactions in Rani Therapeutics Holdings, Inc. stock. As of the latest transaction made, Aspireon Wealth Advisors holds 48,129 shares of RANI stock, worth $25,027. This represents 0.14% of its overall portfolio holdings.
Number of Shares
48,129
Previous 48,129
-0.0%
Holding current value
$25,027
Previous $284,000
12.68%
% of portfolio
0.14%
Previous 0.15%
Shares
2 transactions
Others Institutions Holding RANI
# of Institutions
44Shares Held
6.26MCall Options Held
29.4KPut Options Held
0-
Armistice Capital, LLC New York, NY3.15MShares$1.64 Million0.03% of portfolio
-
Vanguard Group Inc Valley Forge, PA800KShares$415,8330.0% of portfolio
-
Nan Fung Group Holdings LTD Central, K3494KShares$256,6630.48% of portfolio
-
United Services Automobile Association San Antonio, TX303KShares$157,4260.02% of portfolio
-
Geode Capital Management, LLC Boston, MA191KShares$99,0890.0% of portfolio
About Rani Therapeutics Holdings, Inc.
- Ticker RANI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 24,492,000
- Market Cap $12.7M
- Description
- Rani Therapeutics Holdings, Inc. operates as a clinical stage biotherapeutics company that develops orally administered biologics. The company develops the RaniPill capsule, a platform that is intended to replace subcutaneous or IV injection of biologics with oral dosing. Its product pipeline includes RT-101, an octreotide, which has completed P...